Hansa Medical AB (publ) is a Swedish medical stage drug development business founded in 2007. Hansa Medical’s headquarter is located in Lund, IDEON Science Park, conveniently adjacent to Lund University.
Decades of specialized study executed by Professor Lars Björck, Division of Infection Medicine, Faculty of Medication, Lund University, develops the clinical foundation of the business.
The innovation of Hansa Medical’s 2 primary products, IdeS and the HBP-assay www.heparinbindingprotein.com originate from Teacher Björck’s study on the pathogenic germs Streptococcus pyogenes and its communication with the immune system.
Hansa Medical’s shares have actually been traded at NASDAQ OMX First North under the ticker icon HMED since 2007.
IgG-antibodies can be the primary as well as severe root cause of pathogenesis in transplant being rejected as well as in a number of rare autoimmune diseases. Hansa Medical distinctively creates microbial enzymes particular for human IgG-antibodies as well as turn them into prospect medicines.
Hansa Medical brings fast, efficient as well as risk-free therapy options to individuals waiting for transplantation and also to those dealing with serious and severe exacerbations of autoimmune disease, as a result seeking timely inactivation of pathogenic IgG.
Business Purpose & Goals
Researchers – Examinations
Hansa Medical’s aspiration is to offer IgG-inactivating enzymes to clients, worldwide, calling for instantaneous inactivation of pathogenic IgG-antibodies. We will obtain our purpose through a number of goals:
Primarily by doing successful medical trials in stages I, II as well as III on our picked key sign: Desensitisation of sensitised kidney hair transplant clients.
Second of all, accomplishing enrollment in major markets such as the EU and also USA.
Third, seeking scientific development of IdeS in rare and intense IgG-mediated autoimmune conditions.
To bring unorthodox novel treatment choices to patients dealing with unusual yet serious or acute IgG-mediated problems, through well created clinical tests.
- A skilled and committed Management Group
- Fredrik Lindgren
- President and Chief Executive Officer (Leave of absence).
Fredrik has comprehensive experience from Scandinavian life science industry. He has actually held positions as CEO at Karo Bio AB (publ.), a clinical phase biotechnology company focused on nuclear receptors as drug targets as well as chief executive officer at Biolin Scientific AB (publ.), a technology team focused on the growth and also advertising and marketing of logical tools for the international life science as well as materials industry.
He has actually likewise acted as CFO of Wilh.Sonesson AB (currently Midsona), COO of Meaning Eco-friendly Abdominal and as Exec VP of Active Biotech Abdominal. Fredrik functions as chairman and member of the board in numerous Swedish life science business consisting of Larodan Fine Chemicals AB, Exini Diagnostics abdominal (publ.) as well as ProstaLund AB (publ.). Fredrik holds a LL.M. degree from Lund University as well as a Certificate as European Financial Analyst from Stockholm Institution of Service.
Principal Financial Officer and Acting Chief Executive Officer.
Göran Arvidson is CFO of Hansa Medical considering that January 27, 2015. Göran Arvidson has significant experience from the life science industry. He has actually been Executive Vice Head Of State and CFO of Swedish Orphan Biovitrum abdominal (publ), Co-founder of Biovitrum as well as has held senior positions with Procordia abdominal muscle as well as Pharmacia AB. Göran hold a MBA from Stockholm Institution of Economics.
Corporate Development Director.
Emanuel joined Hansa Medical in 2007 counting greater than one decade of operational experience from Scandinavian Pharma and Biotech sector (Biolin Scientific, Polypeptide Labs and also Hansa Medical) acting as Business Analyst, Analytical Drug Store as well as Chief Executive Officer. Emanuel holds an M.Sc. in Design Physics (biophysics core) from Lund College and also the College of The Golden State at Santa Barbara.
Dr. Christian Kjellman.
Principal Scientific Officer.
Christian signed up with Hansa Medical in 2008 after offering at BioInvent AB as Senior citizen Researcher focusing on unique target assessment as well as antibody innovation. Before that, he functioned as Head of Study at the biopharmaceutical advancement company Cartela abdominal, primarily focusing on novel medication target evaluation. He has comprehensive research study experience in cell- and also molecular biology and also as an Aide Professor in Molecular Genetics at Lund University. Christian holds an M.Sc. in Chemical Biology and a Ph.D. in Tumour Immunology from Lund College.
Clinical Study Director.
Dr. Lena Winstedt.
Lena carries considerable experience from clinical advancement of biopharmaceuticals and little molecules. Before joining Hansa Medical in 2011, she worked as Medical Task Supervisor at BioInvent International abdominal concentrating on Stage I scientific tests for biopharmaceuticals in Europe and also in the USA. Before that she operated as International Medical Job Manager at Genmab A/S as well as Professional Study Affiliate at H. Lundbeck Abdominal Muscle. Lena holds an M.Sc. in Molecular Biology from Lund University and the University of Glasgow and a Ph.D. in Microbiology from Lund University.
- A steadfast and visionary Board.
- Birgit Stattin Norinder.
- Chairman of the board.
Birgit has considerable experience from international pharmaceutical and also biotechnology companies in Sweden, the USA and also the United Kingdom. She has actually taken care of numerous r & d departments, resulting in a number of unique as well as approved pharmaceuticals. Amongst lots of points she has actually functioned as chief executive officer and also Chairman at Prolifix Ltd., Senior VP Worldwide Product Growth, Pharmacia & Upjohn and also Dir. Int. Reg. Affairs Department, Glaxo Group Study Ltd. Birgit has actually likewise held a number of board as well as chairman settings of U.K., Swedish and also Norwegian biotechnology firms. Birgit holds an M.Sc. in Drug Store from Uppsala University.
- Chairman of the board considering that 2007.
- In Memoriam.
- 1946 – 2014.
Bo has been energetic as entrepreneur given that 1970 as well as creator of Hansa Medical AB. He has actually held positions as chief executive officer, Board participant, Chairman of the Board or owner of different public business because 1986, consisting of Wihlborgs Fastigheter abdominal muscle (publ), Energetic Biotech AB (publ), Midelfart Sonesson abdominal (publ) (now Midsona), Peltor abdominal (publ) (now 3M Peltor), Biolin Scientific abdominal (publ) and ACAP Invest AB (publ). He is the creator of Active Biotech Abdominal and ACAP Invest Abdominal. Bo presently serves as Chairman of the Board in EXINI Diagnostics abdominal muscle (publ), Hansa Medical AB (publ) and also ProstaLund abdominal (publ). He operates from his company Farstorp. Bo holds an M.Sc. in Economics from Lund University and a Ph.D h.c. from the Faculty of Medicine, Lund University.
Dr. Stina Gestrelius.
Member of the board considering that 2007.
Stina has thirty years of experience in the pharmaceutical as well as biotech sectors. Entrepreneur and also formerly Head of Research at Biora Abdominal as well as Deputy Chief Executive Officer of Medicon Valley Partnership. She is presently participant of the board in BioActive Polymers in Lund Abdominal Muscle and Hansa Medical abdominal muscle (publ.) as well as has held numerous board and also chairman settings of Scandinavian biotechnology firms including Biogaia AB (publ.), Clavis Pharma ASA (publ.) and Lipopeptide abdominal muscle. Stina holds an M.Sc. and also a Ph.D. in Applied Biochemistry And Biology from Lund College.
Per Olof Wallström.
Member of the board since 2011.
Per Olof has comprehensive experience from numerous settings in the international pharmaceutical as well as biotechnology industry, consisting of Senior citizen Management positions at Merck, Astra, Pharmacia as well as Bristol-Myers Squibb. Additionally, he has worked as chief executive officer of Q-Med Abdominal Muscle, Melacure Therapies Abdominal Muscle and Karo Bio AB. He additionally holds board and chairman positions in numerous life science business such as Chemilia Abdominal, Patients Pending Ltd. and also Camurus Abdominal Muscle. Per Olof holds an M.Sc. in Pharmacy from Uppsala University.
Dr. Cindy Wong.
Participant of the board considering that 2012.
Cindy has substantial experience from scientific medicine, medical research, as well as governing requirements for enrollment of brand-new medicinal products as well as biotechnology products. She has actually held elderly settings in the Division of Health And Wellness in Australia as well as at the Swedish Medical Products Agency. She is presently the Chief Medical Officer and Head of Medical Affairs at Q-Med, a Galderma department, in Uppsala, Sweden. In this setting she has supervised the clinical development of a variety of biotechnology items for enrollment in Europe, the United States, China as well as in Japan. Cindy holds a M.D. from the University of Adelaide and also is a medical professional in both inner medication as well as immunopathology qualified in Australia. Cindy is a Fellow of the Royal Australasian College of Physicians and an Other of the Royal University of Pathologists of Australasia.
Member of the board considering that 2014.
Anders is a companion of NXT2B, a life science concentrated equity capital company based in Uppsala. Prior to that, Anders invested ten years at Q-Med, originally as Business- and also Business Controller and later on as Senior Director Corporate Advancement and also Technique for six years. Additionally, he has actually worked as Business Controller in the EMEA region for Pharmacia Corp. and also as auditor at the Swedish Tax Firm (Skatteverket). Anders holds a Bachelor’s degree in Service Administration from Uppsala College.